Strategies to make clinical trials more efficient continue to be an industry focus — for faster time to market, to reduce costs and to deliver much-needed treatments.
Incorporating biomarker-based strategies during the study design phase can improve enrollment, help target treatments to patients that will receive the most benefit and shorten trial timelines.
Download this report to:
- Understand how biomarkers are being used in oncology clinical trials.
- Explore insights into historical oncology trial trends to monitor the effectiveness of strategies.
- Evaluate how you can incorporate biomarkers in your clinical trials.
